Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;97(2):e70233.
doi: 10.1002/jmv.70233.

Microbiological Investigations for Chikungunya Virus in Children With Acute Encephalitis Syndrome in a Non-Outbreak Setting in Southern India

Affiliations

Microbiological Investigations for Chikungunya Virus in Children With Acute Encephalitis Syndrome in a Non-Outbreak Setting in Southern India

Tina Damodar et al. J Med Virol. 2025 Feb.

Abstract

Chikungunya virus (CHIKV) is an emerging cause of acute encephalitis syndrome (AES) in India, with limited data on its role in childhood AES in southern India. We systematically evaluated children with AES in southern India during a non-epidemic period for CHIKV. Serum and cerebrospinal fluid (CSF) samples were tested for CHIKV using IgM ELISA and real-time reverse transcriptase PCR. Amplicon sequencing was performed on PCR-positive samples. Clinical and laboratory features were compared between children with and without CSF CHIKV positivity (PCR/IgM antibodies). Of 376 children with AES, 20 (5.3%) had positive CHIKV tests. Co-infections were common, particularly with scrub typhus. Children presented with diverse symptoms affecting various organ systems. Neurological manifestations included meningism, seizures, cerebellar signs, behavioral abnormalities, cranial nerve involvement, involuntary movements, and hemiparesis/hemiplegia. Children with CSF CHIKV positivity showed more focal neurological deficits and transaminitis, and less musculoskeletal symptoms. Sequencing confirmation of CHIKV was made in all patients with positive CHIKV PCR, revealing a close relationship with 2016 Kenyan and Indian strains, albeit in a different clade within the East/Central/South African genotype. Along with important mutations known to impact CHIKV infectivity, four novel amino acid substitutions were detected in envelope protein coding regions. Our findings underscore the importance of routine and comprehensive CHIKV testing for children with AES, irrespective of season/outbreak. The high rate of co-infections warrants further research. Continued genomic surveillance is essential to monitor emerging mutations with epidemic potential, increased severity and the risk of neurological disease.

PubMed Disclaimer

Conflict of interest statement

Lance Turtle is supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections (NIHR200907) at the University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford. Lance Turtle is based at the University of Liverpool. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health, or Public Health England. Lance Turtle has received consulting fees from MHRA and from AstraZeneca and Synairgen, paid to the University of Liverpool; speakers’ fees from Eisai Ltd; and support for conference attendance from AstraZeneca. Benedict D. Michael is supported to conduct COVID‐19 neuroscience research by the UKRI/MRC (MR/V03605X/1) and by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool. Benedict D. Michael is also supported for additional neurological inflammation research due to viral infection by grants from: the NIHR, the Medical Research Council [MC_PC_19059] the MRC/UKRI (MR/V007181/1), MRC (MR/T028750/1), Wellcome (ISSF201902/3) and Medical Research Foundation (MRF) [MRF‐CPP‐R2‐2022‐100003]. Chitra Pattabiraman and Pramada Prasad were supported by the DBT/Wellcome Trust India Alliance Fellowship (IA/E/15/1/502336) awarded to Chitra Pattabiraman. The other authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Maximum likelihood phylogenetic tree of CHIKV ECSA genotype (n = 461). Figure shows a maximum likelihood tree of CHIKV ECSA sequences based on the region (77–11 313) rooted by the outgroup. Bootstrap support values > 80 are shown. Tips (other than sequences from the study) are labeled as Genbank accession ID of the sequence, country, type of biological sample, and collection date. Branches leading to sequences from the study are highlighted in red. Clades distant from the study sequences have been collapsed.

References

    1. Sunil S., “Current Status of Chikungunya in India,” Frontiers in Microbiology 12 (2021): 695173. - PMC - PubMed
    1. Ward C. E. and Chapman J. I., “Chikungunya in Children: A Clinical Review,” Pediatric Emergency Care 34, no. 7 (2018. July): 510–515. - PubMed
    1. Mehta R., Gerardin P., de Brito C. A. A., Soares C. N., Ferreira M. L. B., and Solomon T., “The Neurological Complications of Chikungunya Virus: A Systematic Review,” Reviews in Medical Virology 28, no. 3 (2018. May): e1978. - PMC - PubMed
    1. Nyamwaya D. K., Thumbi S. M., Bejon P., Warimwe G. M., and Mokaya J., “The Global Burden of Chikungunya Fever Among Children: A Systematic Literature Review and Meta‐Analysis,” PLOS Global Public Health 2, no. 12 (2022. December 21): e0000914. - PMC - PubMed
    1. Thiruvengadam K. V., Kalyanasundaram V., and Rajgopal J., “Clinical and Pathological Studies on Chikungunya Fever in Madras City,” Indian Journal of Medical Research 53, no. 8 (1965. August): 729–744. - PubMed

MeSH terms